Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint

PaperCitations, authors & open-access status

The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 124 citations, 2023 year and gold oa status.

124
Citations
2023
Year
gold
OA Status

Related on ScholarIQ

Ron Handels
Author
The Lancet Regional Health - Europe
Journal
Health Systems, Economic Evaluations, Quality of Life
Topic
Health Systems, Economic Evaluations, Quality of Life
Topic
Pharmaceutical Economics and Policy
Topic
Pharmaceutical studies and practices
Topic
470M+ articles · free account